Susquehanna International Group’s Nymox Pharmaceutical Corp NYMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $7.96K | Buy |
|
|||||
|
2023
Q1 | $13.5K | Sell |
|
|||||
|
2022
Q4 | $14.8K | Buy |
|
|||||
|
2022
Q3 | $15K | Buy |
|
|||||
|
2022
Q2 | $12K | Sell |
|
|||||
|
2022
Q1 | $82K | Sell |
|
|||||
|
2021
Q4 | $86K | Sell |
|
|||||
|
2021
Q3 | $185K | Buy |
|
|||||
|
2021
Q2 | $55K | Buy |
|
|||||
|
2021
Q1 | $74K | Buy |
|
|||||
|
2020
Q4 | $71K | Sell |
|
|||||
|
2020
Q3 | $74K | Buy |
|
|||||
|
2020
Q2 | $63K | Sell |
|
|||||
|
2020
Q1 | $780K | Buy |
|
|||||
|
2019
Q4 | $229K | Buy |
|
|||||
|
2019
Q3 | $26K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $21K | Sell |
|
|||||
|
2018
Q4 | $172K | Sell |
|
|||||
|
2018
Q3 | $710K | Buy |
|
|||||
|
2018
Q2 | $705K | Buy |
|
|||||
|
2018
Q1 | $501K | Sell |
|
|||||
|
2017
Q4 | $614K | Buy |
|
|||||
|
2017
Q3 | $302K | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $753K | Buy |
|
|||||
|
2016
Q4 | $182K | Sell |
|
|||||
|
2016
Q3 | $235K | Buy |
|
|||||
|
2016
Q2 | $83K | Sell |
|
|||||
|
2016
Q1 | $149K | Sell |
|
|||||
|
2015
Q4 | $209K | Buy |
|
|||||
|
2015
Q3 | $126K | Buy |
|
|||||
|
2015
Q2 | – | Sell |
|
|||||
|
2015
Q1 | $9K | Sell |
|
|||||
|
2014
Q4 | $5K | Sell |
|
|||||
|
2014
Q3 | $163K | Buy |
|
|||||
|
2014
Q2 | $82K | Sell |
|
|||||
|
2014
Q1 | $185K | Sell |
|
|||||
|
2013
Q4 | $236K | Sell |
|
|||||
|
2013
Q3 | $328K | Sell |
|
|||||
|
2013
Q2 | $481K | Buy |
|